Indications for Lead Extraction
Cardiac Electrophysiology Clinics · 2024
DOI: 10.1016/j.ccep.2024.08.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiac Electrophysiology Clinics, 2024. Verfasst von Sean D Pokorney. Beteiligte Einrichtung: Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA; Department of Medicine, Duke Clinical Research Institute, Durham, NC 2…. Hauptthemen laut MEDLINE: Device Removal, Defibrillators, Implantable, Pacemaker, Artificial. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
Cardiac implantable electronic devices (CIEDs) are being implanted at increasing rates. Patients with CIEDs require more lead management in contemporary clinical practice, given the increased survival of heart failure patients. There are multiple indications for extraction with the strongest class I indications being in patients with CIED infections. Extraction with complete hardware removal is underutilized and often delayed when it is utilized in patients with CIED infections, resulting in higher mortality. Patient and provider preferences are critical to decision-making when considering extraction. Lead extraction referral and management care pathways are needed in order to optimize care for our patients with CIEDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA; Department of Medicine, Duke Clinical Research Institute, Durham, NC 27710, USA. Electronic address: sean.pokorney@duke.edu.
Zitieren
APA
Pokorney, S. D. (2024). Indications for Lead Extraction. Cardiac Electrophysiology Clinics. https://doi.org/10.1016/j.ccep.2024.08.002
Vancouver
Pokorney SD. Indications for Lead Extraction. Cardiac Electrophysiology Clinics. 2024. doi:10.1016/j.ccep.2024.08.002
BibTeX
@article{Pokorney2024,
author = {Pokorney, Sean D},
title = {Indications for Lead Extraction},
journal = {Cardiac Electrophysiology Clinics},
year = {2024},
doi = {10.1016/j.ccep.2024.08.002}
}
EUVIMED